Viewing Study NCT06959550


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-29 @ 2:13 AM
Study NCT ID: NCT06959550
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2025-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module